Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_assertion type Assertion NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_head.
- NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_assertion description "[Adoptive cell transfer (ACT), either using rapidly expanded tumor infiltrating lymphocytes or T-cell receptor transduced peripheral blood lymphocytes, can be considered one of the most promising approaches in cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_provenance.
- NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_assertion evidence source_evidence_literature NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_provenance.
- NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_assertion SIO_000772 20349059 NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_provenance.
- NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_assertion wasDerivedFrom befree-20140225 NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_provenance.
- NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_assertion wasGeneratedBy ECO_0000203 NP333945.RA72_KPqkpj8Bl-Wyh3kfaJmLLpB0C893C3Ar4_NsZObk130_provenance.